These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 11833075)

  • 21. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
    Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
    J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan.
    Satake M; Uchida H; Arai Y; Anai H; Sakaguchi H; Nagata T; Yamane T; Kichikawa K; Osaki Y; Okazaki M; Higashihara H; Nakamura H; Osuga K; Nakao N; Hirota S
    Cardiovasc Intervent Radiol; 2008; 31(4):756-61. PubMed ID: 18389187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation.
    Ko HK; Ko GY; Yoon HK; Sung KB
    Korean J Radiol; 2007; 8(4):320-7. PubMed ID: 17673843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience.
    Stefanini GF; Amorati P; Biselli M; Mucci F; Celi A; Arienti V; Roversi R; Rossi C; Re G; Gasbarrini G
    Cancer; 1995 May; 75(10):2427-34. PubMed ID: 7736385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.
    Kamada K; Kitamoto M; Aikata H; Kawakami Y; Kono H; Imamura M; Nakanishi T; Chayama K
    Am J Surg; 2002 Sep; 184(3):284-90. PubMed ID: 12354601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization.
    De Santis M; Alborino S; Tartoni PL; Torricelli P; Casolo A; Romagnoli R
    Eur Radiol; 1997; 7(1):10-6. PubMed ID: 9000387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial blood supply to the posterior aspect of segment IV of the liver from the caudate branch: demonstration at CT after iodized oil injection.
    Miyayama S; Matsui O; Taki K; Minami T; Ryu Y; Ito C; Nakamura K; Inoue D; Takamatsu S
    Radiology; 2005 Dec; 237(3):1110-4. PubMed ID: 16251397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.
    Seong J; Keum KC; Han KH; Lee DY; Lee JT; Chon CY; Moon YM; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):393-7. PubMed ID: 10030267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma].
    Chung PJ; Park SY; Kim YI; Yoon KW; Cho SB; Choi SK; Rew JS
    Korean J Gastroenterol; 2009 Aug; 54(2):130-4. PubMed ID: 19696542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma.
    Oi H; Kim T; Kishimoto H; Matsushita M; Tateishi H; Okamura J
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S69-73. PubMed ID: 8137486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
    Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyvinyl alcohol embolization adjuvant to oily chemoembolization in advanced hepatocellular carcinoma with arterioportal shunts.
    Kim YJ; Lee HG; Park JM; Lim YS; Chung MH; Sung MS; Yoo WJ; Lim HW
    Korean J Radiol; 2007; 8(4):311-9. PubMed ID: 17673842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.